IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
93 hedge funds and large institutions have $487M invested in IGM Biosciences in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 33 increasing their positions, 19 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
2.34% more ownership
Funds ownership: 67.77% → 70.11% (+2.3%)
5% less capital invested
Capital invested by funds: $514M → $487M (-$26.9M)
Holders
93
Holding in Top 10
–
Calls
$15M
Puts
$7.91M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$11.1M | |
| 3 | +$7.98M | |
| 4 |
D.E. Shaw & Co
New York
|
+$6.78M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$5.35M |
Top Sellers
| 1 | -$27.4M | |
| 2 | -$15M | |
| 3 | -$3.35M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.61M |
| 5 |
EGP
Entrust Global Partners
New York
|
-$1.94M |